Johnson & Johnson reported earnings results for the fourth quarter and full year ended December 31, 2023. For the fourth quarter, the company reported sales was USD 21,395 million compared to USD 19,939 million a year ago. Net income was USD 4,049 million compared to USD 3,520 million a year ago. Diluted earnings per share from continuing operations was USD 1.7 compared to USD 1.22 a year ago.

For the full year, the company reported sales was USD 85,159 million compared to USD 79,990 million a year ago. Net income was USD 35,153 million compared to USD 17,941 million a year ago. Diluted earnings per share from continuing operations was USD 5.2 compared to USD 6.14 a year ago.